National Comprehensive Cancer Network

NCCN Research & Business Resources

NCCN Flash Updates™

NCCN Flash Updates™ is a new service from NCCN that provides immediate access to updated and new information appearing in the published NCCN Drugs & Biologics Compendium™ and NCCN Clinical Practice Guidelines in Oncology™.

For more information on NCCN Flash Updates™ or to subscribe to this service, please contact:

Jennifer M. Hinkel, MSc
Manager, Business Insights
Telephone: +1 215.690.0250

Archive of past NCCN Flash Updates™

6/23/2009
Multiple Myeloma Guidelines Updated with Numerous Changes to the NCCN Categories of Evidence and Consensus for Induction Therapy Regimens

6/08/2009
CML Guidelines Updated

6/01/2009
Head and Neck Cancers Guidelines updated to include option of PET-CT and CT with contrast in several cancer sites

5/28/2009
Octreotide therapy for asymptomatic patients with recurrent, unresectable carcinoid tumors added to Neuroendocrine Tumors Guidelines

4/28/2009
NCCN Clinical Practice Guidelines in Oncology™ for Central Nervous System Cancers and Venous Thromboembolic Disease Updated

4/13/2009
Everolimus added to National Comprehensive Cancer Network (NCCN) Kidney Cancer Guidelines as subsequent therapy following failure of tyrosine kinase inhibitor therapy (TKI)